PARALLEL ADVISORS, LLC – Corcept Therapeutics Incorporated Transaction History
PARALLEL ADVISORS, LLC portfolio value:
$96.64M
portfolio value
PARALLEL ADVISORS, LLC quarter portfolio value change:
+7.82%
quarter
Corcept Therapeutics Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +38.67% | 1.05M shares | 32.00M | $25.64 | 3.76M |
| Q2 2022 | share | Increase | +39.81% | 774.00K shares | 17.62M | $23.78 | 2.71M |
| Q1 2022 | share | Increase | +7.82% | 140.93K shares | 11.30M | $22.52 | 1.94M |
| Q4 2021 | share | Increase | +4.43% | 76.47K shares | 1.72M | $19.48 | 1.80M |
| Q3 2021 | share | Increase | +3.14% | 52.55K shares | -2.85M | $19.68 | 1.72M |
| Q2 2021 | share | Increase | +7.06% | 110.38K shares | -371K | $22 | 1.67M |
| Q1 2021 | share | Increase | +0.99% | 15.35K shares | -3.30M | $23.79 | 1.56M |
| Q4 2020 | share | Increase | +19.59% | 253.71K shares | 17.97M | $26.16 | 1.54M |
| Q3 2020 | share | Decrease | -7.80% | -109.54K shares | -1.08M | $17.41 | 1.29M |
| Q2 2020 | share | Decrease | -0.10% | -1.45K shares | 6.90M | $16.82 | 1.40M |
| Q1 2020 | share | 0.00% | 0 shares | -295K | $11.89 | 1.40M | |
| Q4 2019 | share | Increase | +10.02% | 128.04K shares | -1.05M | $12.1 | 1.40M |
| Q3 2019 | share | Increase | +49048.12% | 1.27M shares | 18.03M | $14.14 | 1.27M |
| Q2 2019 | share | Increase | 0.00% | 2.6K shares | 29K | $11.15 | 2.6K |